<DOC>
	<DOCNO>NCT00479440</DOCNO>
	<brief_summary>To assess safety tolerability ascend single oral dos SAM-315 , investigational drug , healthy adult subject . To obtain preliminary pharmacokinetic ( PK ) pharmacodynamic ( PD ) profile SAM-315 healthy subject evaluate effect high-fat meal PK SAM-315 , investigation drug , administer healthy adult subject .</brief_summary>
	<brief_title>Study Evaluating Safety , Tolerability , Pharmacokinetics ( PK ) , Pharmacodynamics ( PD ) SAM-315 Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Inclusion criterion : Men woman nonchildbearing potential age 18 45 year Body mass index range 18 30 kg/m2 body weight â‰¥50 kg . Healthy determine investigator basis medical history , physical examination , clinical laboratory test result , vital sign , digital 12lead electrocardiogram ( ECG ) . Alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , creatinine level must within upper limit normal eligibility . Exclusion criterion : Any significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease . Any clinically important deviation normal limit physical examination , vital sign , digital 12lead ECGs , clinical laboratory test result . Consumption caffeinecontaining product ( e.g. , coffee , tea , chocolate , soda ) alcoholic beverage within 48 hour , grapefruit , grapefruitcontaining product prohibit 72 hour study day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>